PayPay Securities’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.9K Hold
28
0.07% 143
2026
Q1
$2.15K Sell
28
-9
-24% -$693 0.07% 168
2025
Q4
$2.94K Buy
37
+8
+28% +$631 0.09% 158
2025
Q3
$2.22K Buy
29
+5
+21% +$343 0.08% 157
2025
Q2
$1.66K Hold
24
0.08% 167
2025
Q1
$1.65K Sell
24
-20
-45% -$1.2K 0.09% 182
2024
Q4
$1.98K Buy
44
+10
+29% +$561 0.09% 195
2024
Q3
$2.14K Sell
34
-18
-35% -$1.05K 0.19% 97
2024
Q2
$3.07K Buy
52
+11
+27% +$688 0.26% 107
2024
Q1
$3.27K Sell
41
-4
-9% -$306 0.16% 129
2023
Q4
$3.56K Buy
45
+9
+25% +$641 0.17% 120
2023
Q3
$2.51K Hold
36
0.11% 139
2023
Q2
$2.49K Sell
36
-5
-12% -$356 0.15% 106
2023
Q1
$3.05K Sell
41
-40
-49% -$3.35K 0.2% 109
2022
Q4
$7.55K Buy
+81
New +$7.82K 0.51% 45

Other funds holding CVS

PayPay Securities's CVS Position: Q2 2026 in Review

PayPay Securities held its CVS Health (CVS) position steady in Q2 2026 at 28 shares worth $2.9K. The position accounts for 0.07% of the portfolio, ranked #143.

PayPay Securities first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.55K in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • PayPay Securities held 28 shares of CVS Health worth $2.9K as of Q2 2026.
  • PayPay Securities left its CVS Health share count unchanged in Q2 2026.
  • CVS Health made up 0.07% of PayPay Securities's portfolio in Q2 2026, its #143 holding.
  • PayPay Securities first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • PayPay Securities's CVS Health position peaked at $7.55K in Q4 2022.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on PayPay Securities's 13F filing for Q2 2026, filed 23 Jul 2026.